朗格汉斯细胞组织细胞增生症伴血小板增多症1例

doi:10.35541/cjd.20201131

Chinese Journal of Dermatology ›› 2022, Vol. 55 ›› Issue (3): 258-259.doi: 10.35541/cjd.20201131

• Case Reports • Previous Articles Next Articles

A case of Langerhans cell histiocytosis with thrombocytosis

Xiang Hongkai, Chen Shisheng, Gao Yu

Department of Dermatology, The Second Affiliated Hospital and Yuying Children′s Hospital of Wenzhou Medical University, Wenzhou 325027, China

Received:2020-11-26 Revised:2021-09-19 Online:2022-03-15 Published:2022-03-03
Contact: Gao Yu E-mail:gaoyu0570@163.com

Abstract

Xiang Hongkai, Chen Shisheng, Gao Yu. A case of Langerhans cell histiocytosis with thrombocytosis[J]. Chinese Journal of Dermatology, 2022, 55(3): 258-259.doi:10.35541/cjd.20201131

［1］	Monsereenusorn C, Rodriguez⁃Galindo C. Clinical characteristics and treatment of Langerhans cell histiocytosis［J］. Hematol Oncol Clin North Am, 2015,29（5）:853⁃873. doi: 10.1016/j.hoc. 2015. 06.005.
［2］	Braier JL, Rosso D, Latella A, et al. Importance of multi⁃lineage hematologic involvement and hypoalbuminemia at diagnosis in patients with "risk⁃organ" multi⁃system Langerhans cell histiocytosis［J］. J Pediatr Hematol Oncol, 2010,32（4）:e122⁃125. doi: 10.1097/MPH.0b013e3181d7acc5.
［3］	Lai CY, Pettit T. Immune thrombocytopenia in a child with refractory Langerhans cell histiocytosis following cladribine containing therapy［J］. J Pediatr Hematol Oncol, 2019,41（8）:620⁃623. doi: 10.1097/MPH.0000000000001243.

A case of Langerhans cell histiocytosis with thrombocytosis

PDF

Knowledge

Abstract

Cite this article

share this article

References ［3］

Related Articles 0

Metrics

Comments

Recommended 10